18F-NaF PET/CT

Detection of osseous metastasis by 18F-NaF/18F-FDG PET/CT versus CT alone.

PURPOSE Sodium fluoride PET (18F-NaF) has recently reemerged as a valuable method for detection of osseous metastasis, with recent work highlighting the potential of coadministered 18F-NaF and 18F-FDG PET/CT in a single combined imaging examination. We further examined the potential of such combined examinations by comparing dual tracer 18F-NaF18/F-FDG PET/CT with CT alone for detection of osse...

Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.

18F-NaF, a PET radiotracer of bone turnover, has shown potential as an imaging biomarker for assessing the response of bone metastases to therapy. This study aimed to evaluate the repeatability of 18F-NaF PET-derived SUV imaging metrics in individual bone lesions from patients in a multicenter study. METHODS Thirty-five castration-resistant prostate cancer patients with multiple metastases un...

Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.

18F-fluorocholine is a specific promising agent for imaging tumor cell proliferation, particularly in prostate cancer, using PET/CT. It is a beneficial tool in the early detection of marrow-based metastases because it excludes distant metastases and evaluates the response to hormone therapy. In addition, 18F-fluorocholine has the potential to differentiate between degenerative and malignant oss...

18F-NaF Positive Bone Metastases of Non 18F-FDG Avid Mucinous Gastric Cancer

Detection of gastric cancer bone metastasis is crucial since its presence is an independent prognostic factor. In this case report, we would like to present 18F-NaF positive bone metastases of non 18F-FDG avid gastric mucinous cancer.

18F-NaF Uptake Is a Marker of Active Calcification and Disease Progression in Patients with Aortic Stenosis Dweck et al: Validation of 18F-NaF Activity in AS